HOME >> MEDICINE >> NEWS
Failed lung cancer drug could help shrink breast tumors

Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce the size of their tumours, suggests a randomised trial published online today (Tuesday May 17, 2005) by THE LANCET ONCOLOGY. Gefitinib has been tested in clinical trials as a treatment for lung cancer but did not help patients live longer overall. Large-scale studies to assess its use in breast cancer, as a treatment prior to surgery, are now being designed, state the authors.

Some breast cancers are hormone sensitive and proliferate in the presence of oestrogen. But in trials where women with this type of breast cancer were given pre-surgical treatment to block hormones only half were found to respond. For this reason many doctors use chemotherapy prior to surgery, which can have negative side effects and cause substantial mortality.

A receptor called EGFR (epidermal growth factor receptor) is present on some hormone sensitive breast cancers and is associated with poor prognosis and failure to respond to hormone-blocking therapy. Charles Coombes (Imperial College and Hammersmith Hospital, London, UK) and colleagues tested whether inhibiting this receptor with a drug called gefitinib might suppress breast cancer cell proliferation. They recruited 56 postmenopausal women with breast cancer that was hormone sensitive and positive for EGFR from hospitals in London. 27 women were assigned gefitinib and an aromatase inhibitor called anastrozole (Arimidex) and 29 were assigned gefitinib and placebo for 4-6 weeks prior to receiving surgery. Tumours were reduced in size by 30-99% in 12 of 22 assigned gefitinib and anastrozole and in 14 of 28 patients assigned gefitinib and placebo.

Professor Coombes comments: "Gefitinib, combined with an aromatase inhibitor, might have a role in the neoadjuvant treatment of breast cancer by reducing the size of the tumour more rapidly. Studies are now being designed to assess this approach."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
16-May-2005


Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. Stomach cancer rate set to fall further 25 percent over next decade
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
7. Pathway links inflammation, angiogenesis and breast cancer
8. Using MRI for diagnosis could help prevent breast cancer progression
9. Electric fields have potential as a cancer treatment
10. Shining light on pancreatic cancer
11. Method shows promise for early detection of pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2018)... ... ... Nanovis , a leader in nanomedicine for the spine, today announced ... devices. , With over 5,000 FortiCore interbodies now implanted, Nanovis plans to further ... with the addition of 22 mm and 25 mm lengths that can be rotated ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... announced today the opening of its newest laboratory located in Cary, NC. Seated ... provide comprehensive services to top U.S. manufacturers and brings additional jobs to the ...
(Date:11/13/2018)... ... 13, 2018 , ... Dahryn Trivedi is on a mission ... the arena of science. , Dahryn has impacted thousands of individuals around the ... relief, inner peace, mental clarity, enhanced intuition, greater happiness and a deep feeling ...
(Date:11/13/2018)... ... 2018 , ... Today, MIT-born startup Atolla launched ... kit includes at home skin analysis tools for measuring oil, moisture, and pH ... formulates the serum to combat a user’s specific skin issues (such as irritation, ...
(Date:11/13/2018)... ... 13, 2018 , ... As part of a new focus ... Medical Technologies, Inc. and has an option to acquire the company, exercisable from ... Their innovative medical technology helps physicians treat their patients through minimally invasive procedures. ...
Breaking Medicine News(10 mins):
(Date:11/13/2018)... ATLANTA (PRWEB) , ... November 13, 2018 , ... ... digital marketing agency offering website design, SEO, social media, digital advertising and physician ... Physicians, hospitals, dentists, and healthcare professionals looking to successfully grow their practice can ...
(Date:11/13/2018)... YORK (PRWEB) , ... November 13, 2018 , ... Thanks to a generous group of ... year, offering our supporters and new donors the chance to double their impact with a ... up to a total of $700,000. , “In the Sermon on the Mount, Jesus tells ...
(Date:11/13/2018)... ... 13, 2018 , ... Through its Microbiome Grant Initiative ... study design, planning, sample collection, and analysis to a team of cancer researchers ... of Clinical Medicine, to compare the gut microbiome in individuals with MM, individuals ...
Breaking Medicine Technology:
Cached News: